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Introduction
Chronic tension-type headache (CTTH) is a clinical
entity where high muscle tension level, in particular in
the trapezium area, may induce a pain sensation in the
same area. Quantum Molecular Resonance (QMR) has
been proved to promote cell regeneration process
through direct cell stimulation which is able to decrease
local inflammatory reaction and consequently pain level.
This study reports a clinical experience of QMR treat-
ment for tension-type headache, associated to I.A.R.A.
(Incontro, Alleanza, Responsabilità, Autonomia) model®,
which increases consciousness of patients who can parti-
cipate actively to QMR therapy. Treatment has been
administrated by specialised nurses.
Materials and methods
From March 2014 to May 2015 a group of 40 patients,
(33 females/7 males), suffering from CTTH, diagnosed
according to the IHS criteria, underwent 8 sessions of
QMR treatment protocol, 2 treatments per week, lasting
20 minutes each. During treatment 3 female patients
withdrew their informed consent. QMR technique con-
sists of applying 2 electrodes on the lower trapezius area,
1 electrode in the median part of the trapezius and a
probe administration on the median trapezius area and
on the forehead region. A prophylactic treatment for
CTTH (antidepressants and/or muscle relaxants) was
used by 89.2% of patients, 24.3% used a symptomatic and
13.5% both. They recorded headache episodes and medi-
cation intake in a daily diary. Follow-up meetings were
fixed at 1, 3, 6 months after the end of the program.
Results
Days of headache/month decreased significantly from
19±9.5 before treatment to 6±8.4 at 1-month follow-up
(p < 0.001) and to 6±8.6 at 3-month follow-up (p<0.001)
(Figure 1). Patients did not report any side effects.
Conclusions
QMR seems to be effective for patients with CTTH and
results are confirmed until the 3-month follow-up.
Treatment is well tolerated and safe for patients. Further
studies and longer follow-up will be necessary to con-
firm the efficacy of this innovative approach.
Written informed consent to publish was obtained
from the patient(s).
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Figure 1 Total number and frequencies of headache episodes and drug administration.
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